Mates Sharon's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Mar 11, 2024
- Accession no.
- 0000950170-24-029583
- Filed
- Mar 11, 2024
- Trade date
- Mar 7-11, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.05M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mates SharonCIK 0001585699 | Director, Officer (Chairman, President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Stock | SSaleDisposed | −31,958 | $66.38 | −$2,121,372.04 | 1,059,063 | Direct | |
| Mar 7, 2024 | Common Stock | SSaleDisposed | −8,754 | $66.93 | −$585,905.22 | 1,050,309 | Direct | |
| Mar 10, 2024 | Common Stock | MOption exerciseAcquired | +20,565 | – | – | 1,070,874 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −14,541 | $64.80 | −$942,256.8 | 1,056,333 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −4,128 | $65.90 | −$272,035.2 | 1,052,205 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −1,590 | $66.81 | −$106,227.9 | 1,050,615 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −306 | $67.33 | −$20,602.98 | 1,050,309 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2024 | Common Stock | MOption exerciseDisposed | −20,565 | $0.00 | $0 | 20,566 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.